Used in pharmaceutical synthesis as a key intermediate for developing bioactive molecules, particularly in the production of central nervous system agents. Its structure supports the development of compounds with potential anticonvulsant and neuroprotective properties. Also employed in the design of novel enzyme inhibitors due to the isoxazole ring’s metabolic stability and favorable binding characteristics. Commonly utilized in medicinal chemistry research for scaffold modification in drug discovery programs.